EUVIMEDEUVIMED entdecken
Crossref

CD11c + T ‐Bet + B Cell Expansion Reveals a Distinct Pathogenic Signature in Autoimmune Liver Diseases

Silvia D'Orso, Francesca La Gualana, Anthony Vignone, Silvia Acati, Francesca Oliva, Annalisa Villa, Francesca Maiorca iD, Milvia Casato iD, Lucia Stefanini iD, Silvia Piconese, Marcelo Teocchi, Giovanna Borsellino und 4 weitere

Liver International · 2026

DOI: 10.1111/liv.70761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Silvia D'Orso und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Hepatitis, Autoimmune, T-Box Domain Proteins, B-Lymphocytes. Die Arbeit nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) are distinct autoimmune liver diseases (AILDs) that differ in pathogenesis and response to therapy. Moreover, some patients exhibit features of both, known as AIH/PBC overlap. Although AILDs are traditionally considered T cell‐driven, B cells have emerged as key contributors to disease progression. In this study, we investigated CD11c + T‐bet + B cells, implicated in different autoimmune diseases and never explored in AILDs.

Methods

Circulating peripheral blood mononuclear cells (PBMC) were isolated from whole blood obtained from patients with AIH ( n = 15), PBC ( n = 8), AIH/PBC overlap syndrome ( n = 11), and healthy donors (HD, n = 12). B and T cell subsets were analysed by conventional and spectral flow‐cytometry. Clinical and laboratory parameters were recorded at the time of sample collection, and serum IL‐21, sCD40L, and BAFF levels were measured by ELISA and by flow cytometry.

Results

Total CD19 + B‐cell frequencies were comparable across groups. However, the canonical atypical B‐cell subset defined as CD11c + T‐bet + CD21 − was significantly expanded in AIH and AIH/PBC patients but not in PBC. Phenotypic characterisation showed that these cells were enriched in double‐negative and naïve‐like B‐cell subsets and displayed the expected chemokine receptor profile of atypical B cells, with higher CXCR3 and lower CXCR5 expression compared with conventional B cells. Circulating follicular helper T cells (cTfh) were increased in AIH and AIH/PBC and correlated with the overall T‐bet + B‐cell compartment. Serum IL‐21 levels were higher in patients with AILDs, particularly in treatment non‐responders.

Conclusions

Expansion of atypical CD11c + T‐bet + B cells, together with increased cTfh frequencies, hallmarks AIH and AIH/PBC. These findings support disease‐specific B‐cell alterations and distinct immune signatures in AIH and AIH/PBC compared with PBC, highlighting potential therapeutic implications for targeting pathogenic B cell subsets in AIH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Cirrhosis, BiliaryHepatitis, AutoimmuneT-Box Domain ProteinsB-LymphocytesCD11c AntigenB-Lymphocyte SubsetsHumansFemaleMaleMiddle AgedInterleukin-21InterleukinsT-bet Transcription FactorAdultFlow CytometryAgedReceptors, CXCR3Case-Control StudiesB-Cell Activating Factor

Stichwörter der Autor:innen

IL‐21primary biliary cholangitis (PBC)atypical B cellsautoimmune hepatitis (AIH)circulating follicular helper T cells (cTfh)

Substanzen

T-Box Domain ProteinsInterleukin-21InterleukinsT-bet Transcription FactorCD11c AntigenReceptors, CXCR3B-Cell Activating Factor

Autor:innen und Institutionen

  • Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Department of Medical Sciences, Immunology and Allergy Unit, University of Turin, Mauriziano Hospital, Turin, Italy.
  • Neuroimmunology and Flow Cytometry Units, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Department of Translational and Precision Medicine, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
  • Division of Gastroenterology, Hepatology and Nutrition, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
  • Department of Internal Medicine, Division of Gastroenterology, Saint Louis University School of Medicine-SSM SLUCare, SLU Hospital, St. Louis, Missouri, USA.

ORCID-Profile: Francesca Maiorca, Milvia Casato, Lucia Stefanini

Zitieren

APA

D'Orso, S., La Gualana, F., Vignone, A., Acati, S., Oliva, F., Villa, A., Maiorca, F., Casato, M., Stefanini, L., Piconese, S., Teocchi, M., Borsellino, G., Basili, S., Alvaro, D., Visentini, M., & Cardinale, V. (2026). CD11c + T ‐Bet + B Cell Expansion Reveals a Distinct Pathogenic Signature in Autoimmune Liver Diseases. Liver International. https://doi.org/10.1111/liv.70761

Vancouver

D'Orso S, La Gualana F, Vignone A, Acati S, Oliva F, Villa A, et al. CD11c + T ‐Bet + B Cell Expansion Reveals a Distinct Pathogenic Signature in Autoimmune Liver Diseases. Liver International. 2026. doi:10.1111/liv.70761

BibTeX
@article{DOrso2026,
  author = {D'Orso, Silvia and La Gualana, Francesca and Vignone, Anthony and Acati, Silvia and Oliva, Francesca and Villa, Annalisa and Maiorca, Francesca and Casato, Milvia and Stefanini, Lucia and Piconese, Silvia and Teocchi, Marcelo and Borsellino, Giovanna and Basili, Stefania and Alvaro, Domenico and Visentini, Marcella and Cardinale, Vincenzo},
  title = {CD11c + T ‐Bet + B Cell Expansion Reveals a Distinct Pathogenic Signature in Autoimmune Liver Diseases},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70761}
}
Kostenlos starten →